The tour company, which operates Transat, missed expectations in
its seasonally slow first quarter as its net loss attributable to shareholders was $ 6.6 million, compared with $ 32.1 million in the prior year.
Not exact matches
Analysts at Oppenheimer tempered their expectations for United Therapeutics Corp's (NASDAQ: UTHR)
first - quarter citing the Maryland - based biotech's historic propensity to log
seasonally slow sales during the start of the year.
Oppenheimer expects United Therapeutics to «report a
seasonally slow»
first quarter when it reports earnings on Wednesday before market open.
According to the analysts, the
first quarter of every year tends to be
seasonally slow for «large - cap biotech companies broadly,» accounting for 23 % of sales for the year (over the last 10 years).